Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan
- 31 August 1994
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 48 (4) , 959-963
- https://doi.org/10.1016/0091-3057(94)90205-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in micePhysiology & Behavior, 1993
- Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressorsPhysiology & Behavior, 1993
- Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-mazeBehavioural Pharmacology, 1992
- Preclinical pharmacology of flesinoxan: A potential anxiolytic and antidepressant drugHuman Psychopharmacology: Clinical and Experimental, 1991
- Buspirone and related compounds as alternative anxiolyticsNeuropeptides, 1991
- 5-HT1A agonist effects on punished responding of squirrel monkeysPharmacology Biochemistry and Behavior, 1990
- Discriminative stimulus properties of flesinoxanPharmacology Biochemistry and Behavior, 1990
- Anticonflict effects of the 5-HT1A compound flesinoxanJournal of Psychopharmacology, 1989
- Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptorsEuropean Journal of Pharmacology, 1988
- The use of a plus-maze to measure anxiety in the mousePsychopharmacology, 1987